MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.drugpo.2026.105275

Медицинская библиотека · The International journal on drug policy · 2026

Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: A population-based interrupted time series analysis.

Young Samantha, Raboud Janet, Dodd Zoë, Barnett-Tapia Carolina, Gomes Tara, Fairbairn Nadia, Bayoumi Ahmed M

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Maintaining access to opioid agonist therapy (OAT) was a key concern at the COVID-19 pandemic onset. Consequently, Ontario introduced guidance for changes to OAT delivery, including relaxed take-home dosing and expanded virtual care. We examined how the pandemic influenced OAT initiation trends.

METHODS

We conducted a population-based, retrospective interrupted time series analysis using linked administrative health data from March 2018 to January 2022 in Ontario, Canada. OAT initiations were defined as new (no OAT prescribed in the preceding two years) prescriptions for methadone, buprenorphine/naloxone, or slow-release oral morphine. Weekly initiation trends were compared before and during two pandemic periods defined by provincial emergency declarations. Analyses were stratified by medication type and sex.

RESULTS

We identified 31,866 new OAT initiations. Immediately after the pandemic began, initiations declined significantly (-36.7/week; 95% CI: -53.3 to -20.1), then gradually returned toward baseline. Overall initiation volumes during the pandemic were not clearly different from pre-pandemic levels, although estimates were imprecise. However, prescribing patterns shifted: we estimate that methadone initiations increased by 2321 (95% CI: 1600 to 3043), while buprenorphine/naloxone initiations declined by 2009 (95% CI: -2783 to -1235) as a result of the pandemic. Sex-stratified trends were consistent with overall findings.

CONCLUSIONS

The pandemic led to a temporary drop in OAT initiations but no long-term decline. A shift toward methadone suggests changing preferences among prescribers and patients, potentially driven by updated guidance and rising drug toxicity. These findings support the need for flexible, low-barrier OAT delivery models that can adapt to public health emergencies and evolving unregulated drug supply risks.

Для цитирования: Young Samantha, Raboud Janet, Dodd Zoë, Barnett-Tapia Carolina, Gomes Tara, Fairbairn Nadia, Bayoumi Ahmed M. Effect of the COVID-19 pandemic on initiations of opioid agonist therapy in Ontario: A population-based interrupted time series analysis.. The International journal on drug policy. 2026. DOI: 10.1016/j.drugpo.2026.105275.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.